| Giving researchers a headache–sex and gender differences in migraine L Al-Hassany, J Haas, M Piccininni, T Kurth, A Maassen Van Den Brink, ... Frontiers in neurology 11, 549038, 2020 | 112 | 2020 |
| CGRP and migraine from a cardiovascular point of view: what do we expect from blocking CGRP? V Favoni, L Giani, L Al-Hassany, GM Asioli, C Butera, I De Boer, ... The journal of headache and pain 20, 1-7, 2019 | 103 | 2019 |
| Calcitonin gene-related peptide-targeting drugs for migraine: how pharmacology might inform treatment decisions L Al-Hassany, PJ Goadsby, AHJ Danser, A MaassenVanDenBrink The Lancet Neurology 21 (3), 284-294, 2022 | 71 | 2022 |
| Assessing methods of measuring medication adherence in chronically ill children–a narrative review L Al-Hassany, SM Kloosterboer, B Dierckx, BCP Koch Patient preference and adherence, 1175-1189, 2019 | 62 | 2019 |
| Primary headache epidemiology in children and adolescents: a systematic review and meta-analysis A Onofri, U Pensato, C Rosignoli, W Wells-Gatnik, E Stanyer, R Ornello, ... The Journal of Headache and Pain 24 (1), 8, 2023 | 45 | 2023 |
| Manipulation of oral medication for children by parents and nurses occurs frequently and is often not supported by instructions AC van der Vossen, L Al‐Hassany, S Buljac, JD Brugma, AG Vulto, ... Acta paediatrica 108 (8), 1475-1481, 2019 | 45 | 2019 |
| Dried blood spot analysis for therapeutic drug monitoring of antipsychotics: drawbacks of its clinical application SM Kloosterboer, BCM de Winter, S Bahmany, L Al-Hassany, A Dekker, ... Therapeutic Drug Monitoring 40 (3), 344-350, 2018 | 44 | 2018 |
| Metabolic aspects of migraine: association with obesity and diabetes mellitus E Rivera-Mancilla, L Al-Hassany, CM Villalón, A MaassenVanDenBrink Frontiers in neurology 12, 686398, 2021 | 36 | 2021 |
| Evaluating rimegepant for the treatment of migraine T de Vries, L Al-Hassany, A MaassenVanDenBrink Expert opinion on pharmacotherapy 22 (8), 973-979, 2021 | 19 | 2021 |
| The sense of stopping migraine prophylaxis L Al-Hassany, HS Lyons, DM Boucherie, F Farham, KS Lange, ... The Journal of Headache and Pain 24 (1), 9, 2023 | 17 | 2023 |
| Future targets for migraine treatment beyond CGRP L Al-Hassany, DM Boucherie, H Creeney, RWA van Drie, F Farham, ... The Journal of Headache and Pain 24 (1), 76, 2023 | 16 | 2023 |
| Prolactin and oxytocin: potential targets for migraine treatment AK Szewczyk, S Ulutas, T Aktürk, L Al-Hassany, C Börner, F Cernigliaro, ... The Journal of Headache and Pain 24 (1), 31, 2023 | 16 | 2023 |
| CGRP-mediated trigeminovascular reactivity in migraine patients treated with erenumab S de Vries Lentsch, L Al-Hassany, MD Ferrari, GM Terwindt, ... Journal of Neurology, Neurosurgery & Psychiatry 93 (8), 911-912, 2022 | 14 | 2022 |
| Targeting CGRP in migraine: a matter of choice and dose L Al-Hassany, AM Van Den Brink The Lancet Neurology 19 (9), 712-713, 2020 | 13 | 2020 |
| A randomized crossover study comparing different tacrolimus formulations to reduce intrapatient variability in tacrolimus exposure in kidney transplant recipients KLW Bunthof, L Al‐Hassany, G Nakshbandi, DA Hesselink, ... Clinical and Translational Science 15 (4), 930-941, 2022 | 10 | 2022 |
| Drug interactions and risks associated with the use of triptans, ditans and monoclonal antibodies in migraine L Al-Hassany, A MaassenVanDenBrink Current Opinion in Neurology 34 (3), 330-338, 2021 | 8 | 2021 |
| European Headache Federation School of Advanced Studies (EHF-SAS). Primary headache epidemiology in children and adolescents: A systematic review and meta-analysis A Onofri, U Pensato, C Rosignoli, W Wells-Gatnik, E Stanyer, R Ornello, ... J. Headache Pain 24 (8), 2023 | 7 | 2023 |
| Migraine and the risk of stroke in a middle-aged and elderly population: a prospective cohort study C Acarsoy, L Fani, L Al-Hassany, BP Berghout, PJ Koudstaal, ... Cephalalgia 43 (1), 03331024221132008, 2023 | 6 | 2023 |
| Could erectile dysfunction be a side effect of CGRP inhibition? A case report L Al-Hassany, T Vries, JA Carpay, A MaassenVanDenBrink Cephalalgia 42 (3), 257-261, 2022 | 6 | 2022 |
| Revisiting dose-finding of monoclonal antibodies in migraine L Al-Hassany, N Karsan, C Lampl, PJ Goadsby, A MaassenVanDenBrink The Journal of Headache and Pain 24 (1), 69, 2023 | 4 | 2023 |
